Suppr超能文献

立体定向术前中性粒细胞与淋巴细胞比值是脑转移瘤预后的预测指标。

Pre-stereotactic radiosurgery neutrophil-to-lymphocyte ratio is a predictor of the prognosis for brain metastases.

机构信息

Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, People's Republic of China.

出版信息

J Neurooncol. 2020 May;147(3):691-700. doi: 10.1007/s11060-020-03477-w. Epub 2020 Apr 6.

Abstract

PURPOSE

The neutrophil-to-lymphocyte ratio (NLR) has been reported to relate to the prognosis of various cancers. The aim of this study was to elucidate the efficiency of pre-treatment NLR as a predictor of outcomes of brain metastasis underwent gamma knife radiosurgery (GKRS).

METHODS

We analyzed 195 cases with brain metastasis underwent GKRS at our institution between January 2015 and April 2018. Patients' clinical and radiographic data were collected.

RESULTS

We identified 458 brain metastases in 195 patients. Optimal dichotomous cutoff values of NLR determined by receiver operating characteristic analysis for local control, distant control and overall survival (OS) were 2.48, 2.74 and 3.13, respectively. The actuarial local control rates of patients with high NLR were 87.4% at 6 months and 76.1% at 12 months, whereas that of patients with low NLR were 94.2% at 6 months and 88.3% at 12 months (P = 0.001). The actuarial distant control rates of patients with high NLR were 31.4% at 6 months and 18.9% at 12 months, whereas that of patients with low NLR were 58.5% at 6 months and 31.3% at 12 months (P = 0.001). The median OS of patients with high and low NLR were 10.0 months and 14.5 months, respectively (P = 0.001). Multivariate analysis demonstrates that high NLR independently predicts local failure (hazard ratio [HR], 2.281; P = 0.003), distant brain failure (HR 1.775; P = 0.002) and poorer overall survival (HR 1.494; P = 0.034).

CONCLUSION

The pre-SRS NLR, a systemic inflammatory marker for treatment response, inversely predicts local control, distant control and OS in patients with brain metastasis.

摘要

目的

中性粒细胞与淋巴细胞比值(NLR)已被报道与各种癌症的预后相关。本研究旨在阐明治疗前 NLR 作为伽玛刀放射外科(GKRS)治疗脑转移瘤患者结局预测因子的效率。

方法

我们分析了 2015 年 1 月至 2018 年 4 月在我院接受 GKRS 治疗的 195 例脑转移瘤患者的临床和影像学资料。

结果

我们共发现 195 例患者的 458 个脑转移灶。通过受试者工作特征分析,确定 NLR 预测局部控制、远处控制和总生存(OS)的最佳二分类截断值分别为 2.48、2.74 和 3.13。高 NLR 组患者的 6 个月和 12 个月局部控制率分别为 87.4%和 76.1%,而低 NLR 组患者的 6 个月和 12 个月局部控制率分别为 94.2%和 88.3%(P=0.001)。高 NLR 组患者的 6 个月和 12 个月远处控制率分别为 31.4%和 18.9%,而低 NLR 组患者的 6 个月和 12 个月远处控制率分别为 58.5%和 31.3%(P=0.001)。高 NLR 组和低 NLR 组患者的中位 OS 分别为 10.0 个月和 14.5 个月(P=0.001)。多变量分析表明,高 NLR 独立预测局部失败(风险比[HR],2.281;P=0.003)、远处脑失败(HR 1.775;P=0.002)和较差的总生存(HR 1.494;P=0.034)。

结论

治疗前 NLR,作为治疗反应的全身炎症标志物,与脑转移瘤患者的局部控制、远处控制和 OS 呈负相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验